Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis

Completed · Not applicable

Conditions studied: Cystic Fibrosis

In brief

The purpose of this study is to determine antimycobacterial drug pharmacokinetics (PK) and pharmacodynamics (PD) in patients with cystic fibrosis (CF) to improve treatment of nontuberculous mycobacterial (NTM) lung disease.

Key facts

Study ID

NCT02372383

Run by

University of Colorado, Denver

People needed

31

Starts

2014-10-01

Expected to finish

2016-06-01

Last updated by the study team

2021-02-11

Who can join

Age: 16 and older, up to 45. Sex: any. Healthy volunteers: accepted.

Where it is running

• Children's Hospital Colroado — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.